Cerity Partners LLC boosted its holdings in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 5.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 241,508 shares of the company's stock after buying an additional 12,427 shares during the quarter. Cerity Partners LLC's holdings in Corteva were worth $15,198,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently bought and sold shares of the business. Sepio Capital LP grew its position in shares of Corteva by 3.2% in the fourth quarter. Sepio Capital LP now owns 5,361 shares of the company's stock valued at $305,000 after purchasing an additional 166 shares during the last quarter. Allred Capital Management LLC grew its position in shares of Corteva by 3.2% in the fourth quarter. Allred Capital Management LLC now owns 5,447 shares of the company's stock valued at $310,000 after purchasing an additional 171 shares during the last quarter. NTV Asset Management LLC grew its position in shares of Corteva by 3.3% in the first quarter. NTV Asset Management LLC now owns 5,457 shares of the company's stock valued at $343,000 after purchasing an additional 173 shares during the last quarter. Avantax Planning Partners Inc. grew its position in shares of Corteva by 4.1% in the first quarter. Avantax Planning Partners Inc. now owns 4,539 shares of the company's stock valued at $286,000 after purchasing an additional 178 shares during the last quarter. Finally, PFG Investments LLC grew its position in shares of Corteva by 1.4% in the first quarter. PFG Investments LLC now owns 12,867 shares of the company's stock valued at $810,000 after purchasing an additional 180 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company's stock.
Analysts Set New Price Targets
Several equities analysts have recently commented on the company. BMO Capital Markets upped their target price on Corteva from $74.00 to $86.00 and gave the company an "outperform" rating in a research report on Tuesday, July 8th. Barclays boosted their price target on Corteva from $70.00 to $75.00 and gave the company an "equal weight" rating in a research note on Monday, July 7th. Wells Fargo & Company boosted their price target on Corteva from $79.00 to $82.00 and gave the company an "overweight" rating in a research note on Monday, June 23rd. UBS Group boosted their price target on Corteva from $76.00 to $90.00 and gave the company a "buy" rating in a research note on Wednesday, July 9th. Finally, Argus upgraded Corteva from a "hold" rating to a "buy" rating and set a $69.00 price target for the company in a research note on Monday, March 31st. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, Corteva presently has a consensus rating of "Moderate Buy" and a consensus price target of $75.54.
View Our Latest Report on Corteva
Corteva Stock Down 1.8%
NYSE CTVA opened at $73.50 on Monday. The business has a fifty day moving average price of $71.45 and a two-hundred day moving average price of $64.70. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.44 and a quick ratio of 1.00. Corteva, Inc. has a fifty-two week low of $50.30 and a fifty-two week high of $77.41. The stock has a market capitalization of $50.14 billion, a PE ratio of 44.82, a PEG ratio of 1.88 and a beta of 0.76.
Corteva (NYSE:CTVA - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $1.13 earnings per share for the quarter, topping the consensus estimate of $0.88 by $0.25. Corteva had a return on equity of 7.84% and a net margin of 6.77%. The firm had revenue of $4.42 billion during the quarter, compared to analysts' expectations of $4.56 billion. During the same period in the prior year, the company earned $0.89 earnings per share. The company's quarterly revenue was down 1.7% on a year-over-year basis. Equities analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.
Corteva Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Monday, June 16th. Stockholders of record on Friday, May 2nd were issued a dividend of $0.17 per share. The ex-dividend date was Monday, June 2nd. This represents a $0.68 annualized dividend and a dividend yield of 0.93%. Corteva's dividend payout ratio (DPR) is presently 41.46%.
About Corteva
(
Free Report)
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.